Login
$AQST
$3.76 +$0.00 (0.04%) After hours

Company Executives

Officer Age In this role Joined 2025 pay Source
Daniel Barber Also a director
President, Chief Executive Officer and Director
50 Not stated Not stated $3,493,559
A. Ernest Toth, Jr.
Chief Financial Officer
67 Since 2020
6 years
2020 $1,323,547
Cassie Jung
Chief Operating Officer
47 Not stated 2004 Not reported
Peter Boyd
Chief People Officer
60 Not stated 2013 Not reported
Matthew W. Davis
Chief Development Officer
60 Not stated 2025 Not reported
Matthew Greenhawt
Chief Medical Officer
52 Not stated 2026 Not reported
Sherry Korczynski
Chief Commercial Officer
56 Not stated 2024 Not reported
Thomas A. Zalewski
Chief Legal Officer and Chief Compliance Officer
54 Since 2026
this year
2026 Not reported
Melina T. Cioffi
Senior Vice President - Regulatory Affairs
43 Not stated 2020 Not reported
Lori J Braender
Corporate Secretary
Title from the Form 4 dated May 7, 2026
Not stated Not stated Not stated $1,348,238

Each officer opens the passage of the filing that names them. A title that changed since the list comes from the officer's latest Form 3, 4 or 5, and its start year is not stated there. "Not stated" means the filing does not say. Pay is the proxy's Summary Compensation Table, which reports only the named executive officers.

Board of Directors

From the proxy statement filed Apr 24, 2026 · updated by the 8-K of Sep 29, 2026

Directors
8
serving now
Independent
7 of 8
stated in the proxy
Average tenure
8.7 years
from year joined
CEO also chairs the board
No
Gregory B. Brown, M.D.
Director On board Independent Other public boards 2025 pay Source
Gregory B. Brown, M.D.
2007
19 years
Independent Lisata Therapeutics, Inc. $274,641
Daniel Barber
2022
4 years
Not independent None stated Paid as CEO
John S. Cochran
2004
22 years
Independent None stated $240,919
Abigail L. Jenkins
2024
2 years
Independent None stated $200,917
Julie Krop, M.D.
2021
5 years
Independent None stated $233,220
Marco Taglietti, M.D.
2021
5 years
Independent None stated $213,412
Timothy E. Morris
2022
4 years
Independent DBV Technologies $237,612
Richard J. Daly Joined Oct 14, 2026
- Independent - -

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive. A director marked Joined was added by an 8-K; their row opens that 8-K, and a dash is a value it does not give.

5 disclosed in the proxy filed Apr 24, 2026
Daniel Barber
registration rights holder under his employment agreement
Amount not stated

Registration rights granted to Mr. Barber pursuant to his employment agreement; shares registered for resale on Form S-3 filings dated September 11, 2019 and January 8, 2021.

MRX Partners LLC, Monoline RX L.P., Monoline Rx II, L.P., Monoline Rx III, L.P., Monoline Rx Genpar, MonoSol Investors L.P., Douglas K. Bratton, Peter Boyd, Lori Braender, Gregory B. Brown, M.D. and John S. Cochran
holders granted registration rights
Amount not stated

Registration rights granted to these related parties, with pro rata reduction provisions on inclusion in future registered offerings.

each of our directors and executive officers
director or executive officer
Amount not stated

Indemnification agreements providing contractual rights to indemnification and expense advancement.

Daniel Barber
participant in Capital Funding Transaction
Amount not stated
June 8, 2022

Purchased 91,743 shares of common stock at $1.09 per share and received a warrant for the same number of shares at $0.96 per share in the June 2022 capital funding program.

Lori Braender
participant in Capital Funding Transaction
Amount not stated
June 8, 2022

Purchased 13,761 shares of common stock at $1.09 per share and received a warrant for the same number of shares at $0.96 per share in the June 2022 capital funding program.

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support